Zumiez Inc. (ZUMZ) Drops 6.25% on January 19

Equities Staff |

Zumiez Inc. (ZUMZ) was one of the Russell 2000's biggest losers for Tuesday January 19 as the stock slid 6.25% to $15.91, a loss of $-1.06 per share. Starting at an opening price of $17.15 a share, the stock traded between $15.79 and $17.48 over the course of the trading day. Volume was 210,890 shares over 2,123 trades, against an average daily volume of 660,094 shares and a total float of 26.69 million.

The losses send Zumiez Inc. down to a market cap of $424.57 million. In the last year, Zumiez Inc. has traded between $40.64 and $11.53, and its 50-day SMA is currently $15.69 and 200-day SMA is $22.78.

The stock has a P/E Ratio of 14.8.

Zumiez Inc is a multi-channel specialty retailer. It is engaged in the retail sales of apparel, footwear, accessories and hardgoods rooted in youth culture as expressed through music, art, fashion and action sports lifestyle for young men and women.

Zumiez Inc. is based out of Lynnwood, WA and has some 6,500 employees. Its CEO is Richard M. Brooks.

For a complete fundamental analysis analysis of Zumiez Inc., check out Equities.com’s Stock Valuation Analysis report for ZUMZ. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets

WayBetter

The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…

Almond Smart Home Router by Securifi

Securifi sells user friendly touch screen routers that also have support for IoT/home automation.Securifi’s Almond revolutionized wireless router setup with its easy to use Touchscreen Interface in 2012. Now our…